These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18831442)

  • 1. [Discontinuation of subsidizing of certain antihypertensive agents is not well thought-out].
    Berggren B; Lindström T; Nyström F; Cizinsky S; Weiss L; Willenheimer R
    Lakartidningen; 2008 Aug 27-Sep 2; 105(35):2345-6. PubMed ID: 18831442
    [No Abstract]   [Full Text] [Related]  

  • 2. [Non-biased (?) blood pressure experts criticize LFN].
    Hernborg A
    Lakartidningen; 2008 Sep 17-23; 105(38):2593-4. PubMed ID: 18846866
    [No Abstract]   [Full Text] [Related]  

  • 3. Out-of-pocket costs to users: medicine options for hypertension.
    Arredondo A
    Am J Hypertens; 2008 May; 21(5):492. PubMed ID: 18437138
    [No Abstract]   [Full Text] [Related]  

  • 4. [Decisions by the state, county council's money and my patient. Consequences of the LFN survey of antihypertensive agents].
    André M; Andersén-Karlsson E; Landahl S; Löfmark R; Silfverhielm B; Skoglund I
    Lakartidningen; 2008 May 21-27; 105(21):1549-50. PubMed ID: 18574990
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug information--national decision needed].
    Ohman U; Nilsson A
    Lakartidningen; 2008 Jul 9-22; 105(28-29):2038. PubMed ID: 18711826
    [No Abstract]   [Full Text] [Related]  

  • 6. [TLV meets criticism: costs of antihypertensive agents can and should be reduced].
    Edling A; Löfmark R; Vinge E; Carlsson P; André M; Melltorp G; Edhag O; Dahlqvist R; Andersson I; Magnusson D
    Lakartidningen; 2008 Sep 17-23; 105(38):2592-3. PubMed ID: 18846865
    [No Abstract]   [Full Text] [Related]  

  • 7. [A reply on subsidizing of antihypertensive agents: the problem is exceptional undertreatment of hypertension].
    Willenheimer R; Nyström F; Berggren B; Lindström T; Cizinsky S; Weiss L
    Lakartidningen; 2008 Oct 22-28; 105(43):3055-6. PubMed ID: 19024623
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaceutical Benefits Scheme.
    Louis WJ; O'Callaghan CJ; Krum H; Mander AG; Louis ES
    Med J Aust; 1994 Jul; 161(2):174. PubMed ID: 8028551
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost analysis of glaucoma medications.
    Fiscella RG; Jensen MK
    Am J Ophthalmol; 2008 Jun; 145(6):1108-9; author reply 1109. PubMed ID: 18503789
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmaceutical Benefits Scheme (PBS).
    Louis WJ; O'Callaghan CJ; Krum H; Mander AG; Louis ES
    Med J Aust; 1994 Mar; 160(5):306-7. PubMed ID: 8107635
    [No Abstract]   [Full Text] [Related]  

  • 11. Prescription benefit costs rise less steeply.
    Manag Care; 2008 Jun; 17(6):53. PubMed ID: 18624171
    [No Abstract]   [Full Text] [Related]  

  • 12. DAKOTACARE update: What are we doing about prescription costs?
    Krafka TL
    S D Med; 2007 Jun; 60(6):243-4. PubMed ID: 17649865
    [No Abstract]   [Full Text] [Related]  

  • 13. Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals?
    Granlund D
    Soc Sci Med; 2009 Dec; 69(11):1643-50. PubMed ID: 19815322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [No value for money with certain antihypertensive agents].
    Edling A; Löfmark R; Vinge E; Carlsson P; André M; Melltorp G; Edhag O; Dahlqvist R; Andersson I; Magnusson D
    Lakartidningen; 2008 Nov 26-Dec 9; 105(48-49):3565. PubMed ID: 19133587
    [No Abstract]   [Full Text] [Related]  

  • 15. [Money, hypertension and calcium antagonists].
    Hernborg A
    Lakartidningen; 1996 Sep; 93(39):3348. PubMed ID: 8926800
    [No Abstract]   [Full Text] [Related]  

  • 16. Subsidizing pharmaceutical prescriptions: the experience of Denmark, Finland, Norway and Sweden.
    Lindgren B; Silverberg R
    Soc Sci Med; 1985; 21(10):1089-96. PubMed ID: 4081814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Article by A Jain: Does homeopathy reduce the cost of conventional drug prescribing?
    Ernst E
    Homeopathy; 2003 Oct; 92(4):233; author reply 233. PubMed ID: 14587695
    [No Abstract]   [Full Text] [Related]  

  • 18. [Should we assess the cost of a drug before prescribing it?].
    Giner Valero M; Feliu Sagalá M; López Martínez A; Gracia Romero L
    Aten Primaria; 1996 Feb; 17(3):233-4. PubMed ID: 8664439
    [No Abstract]   [Full Text] [Related]  

  • 19. Lowering patient drug acquisition costs to improve health outcomes and costs.
    Mahoney JJ
    Manag Care Interface; 2006 Apr; 19(4):13. PubMed ID: 16689022
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fully possible to reduce the costs of hypertension treatment].
    Wettermark B; Angman A; Hjemdahl P
    Lakartidningen; 2009 Jun 3-9; 106(23):1558-62. PubMed ID: 19583013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.